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(DEBS) of Sacckavopolyspora erytkraea, which synthesizes activity in vitro. 
the aglycone core of the antibiotic erythromycin A, con- Results: The purified DEBSl-TE multienzyme catalyzes 
tains some 30 active sites distributed between three mul- synthesis of triketide lactones in vitro.The synthase specif- 
tienzyme polypeptides (designated DEBSl-3). This ically uses the (25’)-isomer of methylmalonyl-CoA, as 
complexity has hitherto frustrated mechanistic analysis of previously proposed, but has a more relaxed specificity for 
such enzymes. We previously produced a mutant strain of the starter unit than in vivo. 
S. erytkraea in which the chain-terminating cyclase Conclusions: We have obtained a purified polyketide 
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Introduction 
Complex polyketides are natural products, found pre- 
dominantly in Streptomyces and related filamentous bacte- 
ria, that exhibit an impressive range of antibiotic, 
anticancer, antiparasite and immunosuppressant activities. 
Despite their apparent structural diversity, they are syn- 
thesi.zed by a common pathway in which units derived 
from acetate or propionate are condensed onto the 
growing chain in a process resembling fatty acid biosyn- 
thesis [1,2]. The intermediates remain bound to the 
polyketide synthase (PKS) during multiple cycles of 
chain extension and (to a variable extent) reduction of 
the B-keto group formed in each condensation. The 
structural variation between naturally occurring poly- 
ketides arises largely from the way in which each PKS 
controls the number and type of units added, and from 
the extent and stereochemistry of reduction at each 
cycle. Still greater diversity is produced by the action of 
regiospecific glycosylases, methyltransferases and oxidative 
enzymes on the product of the PKS. 
Complex reduced polyketides, such as the macrolides 
and polyethers, are synthesized in bacteria on multifunc- 
tional or type I PKSs that contain a separate set, or 
module, of enzymatic activities for every round of chain 
extension 13-61. For example, the clinically-important 
antibiotic erythromycin A is derived from propionyl- 
CoA and six molecules of (2S)-methylmalonyl-CoA [7], 
through the sequential action of six such modules 
housed in the three multienzyme polypeptides [8] of 
6-deoxyerythronolide B synthase (DEBS) (Fig. 1). The 
most remarkable example studied thus far is the PKS for 
the immunosuppressant rapamycin from Stveptomycer 
hygrorcopicus, which contains 14 modules contained 
within only three huge multienzyme polypeptides [9]. 
Progress in understanding the enzymology of such 
modular type I systems has been frustrated by the lack of 
a cell-free system to study polyketide chain synthesis by 
any of these multienzymes, although several partial reac- 
tions of DEBS have been successfully assayed in vitro 
[7,10,11]. We recently introduced [12] a novel, efficient 
and potentially general method for the controlled early 
release of polyketide chains from a modular type I PKS, 
by relocation of the cyclase/thioesterase (TE) domain 
from DEBS3, which normally catalyzes the fifth and 
sixth rounds of chain extension, to the carboxyl-terminus 
of DEBSl, which catalyzes the first two rounds (Fig. 1). 
Mutants of S. erythruea [12] or of S. coelicolor [13] that lack 
endogenous DEBS genes but express the chimaeric 
DEBSl-TE fusion protein were shown to produce the 
expected triketide lactone 1B (Fig. 1) in good yield, 
together with variable amounts of a second triketide 
lactone 1A. 
We show here that cell extracts from such a strain are 
also able to synthesize triketide lactones 1A and lB, 
in the presence of methylmalonyl-CoA, an acyl-CoA 
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(such as propionyl-CoA), and NADPH. Furthermore, 
DEBSl-TE has been purified from the extracts to 
homogeneity and retains its activity. We report here the 
use of this in vitro system to explore several important 
aspects of the specificity and stereospecificity of a typical 
modular polyketide synthase. 
Results and discussion 
Demonstration of cell-free polyketide biosynthesis 
Cell extracts were prepared from the DEBSl-TE- 
expressing S. evythraea strain JCBlOl as described in 
Materials and methods, and used immediately in experi- 
ments to detect the conversion of propionyl-CoA and 
methylmalonyl-Cob into triketide lactone 1B. Radio- 
activity was added in the form of either [14C]-propionyl- 
CoA or [14C]-(R,S)-methylmalonyl-CoA, or both, and 
the reaction mixtures were quenched by extraction with 
ethyl acetate. The radioactive products were separated 
Fig. 1. The domain organization of the 
‘triketide lactone synthase’ (DEBSl-TE). 
Each protein module contains an acyl 
carrier protein (ACP), an acyltransferase 
(AT), a B-ketoacyl-ACP synthase (KS) 
and B-ketoacyl-ACP reductase (KR). The 
thioesterase-cyclase (TE) releases the 
triketide lactone product (normally 
compound 1 B) from the synthase [I 21. 
either by thin-layer chromatography (TLC), or by 
normal-phase or reverse-phase high-pressure liquid 
chromatography (HPLC), and their relative mobilities or 
elution times were compared with those of authentic 
[14C]-triketide lactone 1B. 
A typical profile for the production of radiolabelled com- 
pound 1B over time is shown in Fig. 2, in an experiment 
in which the extract was incubated with propionyl-CoA, 
(R,S)-methylmalonyl-CoA, and NADPH. Purified 
methylmalonyl-CoA epimerase from Propionibactevium 
shermanii [14] was added to ensure rapid equilibration of 
the two stereoisomers, as only (2S)-methylmalonyl-CoA 
is apparently used by DEBS [7]. 
Although the concentrations of propionyl-CoA and 
methylmalonyl-Cod used here are unlikely to be 
optimal, this simple in vitro system has allowed several 
Time (mins) 
Fig. 2. Cell extracts containing 
DEBSI-TE generate triketide lactones in 
vitro. The figure shows production of 
14C-labelled triketide lactones IA and 
IB from 14C-labelled 300 t.t.M propi- 
onyl-CoA, 600 ~.LM (27nCi) (RS)-methyl- 
malonyl-CoA, and 600 FM NADPH in 
the presence of methylmalonyl-CoA 
epimerase in cell extracts of S. erytbraea 
at different time points. The lactones 
were separated on silica TLC plates and 
radioactivity was detected by two- 
dimensional phosphorimaging. Lactone 
1A has R, 0.58, 1 B has R, 0.47. The inset 
summarizes the increase in production 
of IA (lower curve) and 1B (upper 
curve) with time. Production is mea- 
sured in arbitrary units. The material at 
Rf 0.28 is unidentified. For details see 
the text. 
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other features of polyketide chain extension to be exam- 
ined, for example, by using well known inhibitors of spe- 
cific enzymatic activities.We previously showed [14] that 
the active site serine of DEBSl-TE, Ser3029, reacts 
rapidly with the serine protease inhibitor phenyl- 
methanesulfonyl fluoride (PMSF), and that alteration of 
this residue by site-directed mutagenesis caused a > lOO- 
fold decrease in the rate of triketide lactone synthesis by 
chimaeric DEBSl-TE in vivo [12]. We therefore antici- 
pated that PMSF would affect chain release in the in vitro 
system, and indeed addition of 1mM PMSF reduced 
produ.ction of the radiolabelled compound 1B to 65% of 
the amount produced in the control incubation (data not 
shown). Cerulenin is an inhibitor of fatty acid synthases 
from almost all sources [15], and also inhibits production 
of compound 1B. Compared to a control incubation, the 
presence of 0.1 mM cerulenin reduced the rate of incor- 
poration 2-fold, and 1 mM cerulenin reduced the rate 
lo-fold (data not shown). Cerulenin probably exerts its 
effect through specific covalent modification of the 
active site of one or both of the ketoacyl-ACP synthase 
activities in DEBSl, as has been previously demonstrated 
for fatty acid synthase [ 161. 
Relaxed specificity for the starter unit 
The data in Figure 2 illustrate another feature of the cell- 
free enzymatic synthesis of triketide lactone. An addi- 
tional major radiolabelled species is produced in parallel 
with compound 1B. This product co-migrates on TLC 
and HPLC with an authentic synthetic sample of com- 
pound lA, the triketide lactone derived from use of an 
acetate rather than a propionate starter unit.The relative 
proportions of compounds 1B and 1A may be altered in 
the expected direction by the addition of either acetyl- 
CoA or greater amounts of propionyl-CoA to the stan- 
dard reaction mixture (data not shown). The results are 
consistent with the idea that the cell extract contains 
both endogenous acetyl-CoA and propionyl-CoA, and 
that additional amounts of propionyl-Cob may be 
derived by in ritu decarboxylation of methylmalonyl- 
CoA. An engineered strain of S. coelicolor containing the 
DEBSl-thioesterase has been shown previously to 
produce a mixture of compounds 1A and lB, with com- 
pound 1A as the major product [13]. For reasons that are 
not clear, DEBSl alone, when expressed using the iden- 
tical system in S. coelicolor, is reported by others to 
produce only compound 1B [17]. 
Polyketide production by purified DEBSl-TE 
The DEBSl-TE multienzyme was purified to 90-95 % 
homogeneity from S. erythmeu JCBlOl by methods that 
were previously successful for the native DEBS multien- 
zymes [8,10] and for DEBSS over-expressed in Esckerickiu 
coli [18] .The purified enzyme was used in another series 
of experiments to establish the extent to which alterna- 
tive starter units could be used by the polyketide synthase. 
The incubations contained [14C]-methylmalonyl-CoA 
and either acetyl-, propionyl-, n-butyryl-, iso-butyryl-, 
n-valeryl-, ire-valeryl-, n-hexanoyl- or crotonoyl-Cod, 
and the products were extracted and analyzed as before. 
As summarized in Figure 3, substantial amounts of new 
product were obtained from the incubations containing 
acetyl-, n-butyryl- and iso-butyryl-CoA, while all product 
mixtures also contained some propionate-derived mater- 
ial due to partial decarboxylation of the methylmalonyl- 
CoA. The radioactive products lA, 1B and 1C all 
co-migrated with authentic synthetic materials in three 
different HPLC and TLC systems. 
Based on these results, it appears that the purified 
DEBSl-TE multienzyme not only retains its activity, 
but that it requires no extraneous cofactors other than 
NADPH. NADH did not function at all as a cofactor 
(data not shown). These data provide firm evidence for 
in vitro synthesis of polyketide chains on a purified 
modular PKS. 
Stereospecificity of polyketide chain extension 
We have recently shown that acylation of the methyl- 
malonyl-CoA:acyl carrier protein acyltransferase (AT) 
domains from all six modules of DEBS is highly specific 
for the (2s)- stereoisomer of methylmalonyl-Cob [7]. 
Fig. 3.. A variety of starter units can be 
efficiently used by purified DEBSI-TE. 
The figure shows the production of dif- 
ferent 14C-labeiled lactones l(A-D) by 
purified DEBSI-TE from the corre- 
sponding starter acyl-CoA. The lactones 
were separated on silica TLC plates and 
radioactivity was detected by two- 
dimensional phosphorimaging. 
2.5 
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The acyl group is subsequently transferred to water in 
the absence of polyketide chain growth. The availability 
of purified DEBSl-TE multienzyme provided the 
means to check whether the same stereospecificity is 
exercised during normal chain extension. 
(R,S)-[14C]-methylmalonyl-CoA was pre-incubated with 
varying amounts of transcarboxylase (which specifically 
decarboxylates the (2S)-isomer) under conditions that 
ensure that the reaction is irreversible [7] (Fig. 4). The 
reaction with DEBSl-TE was then initiated and the 
triketide lactone products were detected as before. The 
amount of triketide lactone product fell sharply as the 
amount of added transcarboxylase in the pre-incubation 
was increased (Fig. 4a). Addition of purified methyl- 
malonyl-CoA epimerase (which specifically interconverts 
the two isomers of methylmalonyl-CoA) along with 
transcarboxylase, however, caused a significant increase in 
the amount of product compared to that obtained in the 
absence of epimerase (Fig, 4a). The simplest interpreta- 
tion of these results is that the levels of polyketide syn- 
thesis are partly restored when the (25’)-isomer removed 
by the action of the transcarboxylase is restored by gen- 
eration from the (2R)-isomer. The complementary 
experiment was also carried out, in which methyl- 
malonyl-CoA mutase [19] (which specifically uses (2R)- 
methylmalonyl-Cob as a substrate) was added in 
increasing amounts under conditions where the succinyl- 
CoA product is irreversibly hydrolyzed to succinate [7]. 
The loss of the (2R)-isomer had almost no effect on the 
amount of triketide lactone formed (Fig. 4b). When 
epimerase was added, causing (2.S)-methylmalonyl-CoA 
to be depleted as well, the amount of lactone formed 
dropped to 35 % of the amount found in the absence of 
this enzyme. We conclude that (2s)-methylmalonyl-CoA 
specifically promotes polyketide synthesis whereas the 
2R isomer does not, and that the stereospecificity we 
previously observed for the partial hydrolytic reactions 
on DEBS is also seen for chain synthesis. In other words, 
the PIG requires (2s)-methylmalonyl-CoA as an exten- 
der unit at all AT domains.This means, as previously pro- 
posed [7], that the stereochemical variation observed in 
complex macrolides must be the outcome of additional, 
as yet unidentified, enzymatic steps on the synthase. 
Mass spectrometric analysis of triketide lactones 1 B and 1 C 
High resolution mass spectrometric analysis was used to 
confirm the identity of the triketide lactones generated 
in vitro. Cell-free extracts of S. erythvded contain no 
n-butyryl-CoA, making this a convenient starter unit to 
monitor turnover of unlabelled substrates into triketide 
lactone 1C. The products of a standard incubation in 
which n-butyryl-CoA replaced propionyl-Cob were 
extracted and purified by HPLC. Material eluting at the 
same position as authentic 1C was analyzed by high- 
resolution electrospray mass spectrometry, in the 
absence (Fig. 5a) or presence (Fig. 5b) of added sodium 
ions. The addition of sodium ions produces a shift in 
the molecular ion peak and a reduction in the amount 
of dehydration occurring in the spectrometer. The 
masses of the principal peaks in the spectra were in 
close agreement with the values expected for the mole- 
cular ion of protonated compound 1C (MH+= 187.2), 
for a dehydrated species (MH’-18 = 169.0), and for the 
(a) 
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0 
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Fig. 4. Triketide lactone production by 
purified DEBSI-TE is stereospecific. (a) 
Reaction schematic. (b) When (25) 
methylmalonyl-CoA was selectively 
removed from the (R.7) mixture by 
increasing amounts of transcarboxylase, 
the efficiency of [14C]-triketide lactone 
production is progressively decreased: 
sample 1, no transcarboxylase; 2, 0.2 
mu; 3, 2 mu; 4, 20 mu; 5, 200 mU; 
sample 6 as sample 5, but with 200 mU 
methylmalonyl-CoA epimerase. (c) 
Selective removal of (2R)-methyl- 
malonyl-CoA by increasing amounts of 
methylmalonyl-CoA mutase had no 
effect: sample 1, no methylmalonyl-CoA 
mutase; 2, 0.2 mu; 3, 2 mu; 4, 20 mu; 
5, 200 mu; sample 6 as sample 5, but 
with 200 mU methylmalonyl-CoA 
epimerase. 
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Fig. 5. Identification of lactone IC produced in vitro by electro- 
spray mass spectrometry. (a) Spectrum in acid conditions 
showing the molecular ion MH+ (187.2) and a dehydration 
product MH+-18 (169.1). (b) Spectrum in the presence of Na+ 
ions, showing the ion MNa+ (209.1). 
sodium adduct of compound 1C (MNa+= 209.1). The 
two molecular ion species were analyzed by high reso- 
lution mass spectrometry and gave excellent agreement 
with the required masses (found 187.13423, C,,H,,O, 
requires 187.13342; found 209.11533, C,,H,,O,Na 
requires 209.11539). 
Conhrmation of the identity of the triketide lactone 
1B synthesized in vitro was obtained by using specifi- 
tally-deuterated propionyl-CoA as a substrate. To 
redu’ce competition by endogenous sources of starter 
units, the S. erythmeu extract was depleted of small mol- 
ecules by gel filtration. The products of the incubation 
were extracted with ethyl acetate, purified using 
reversed-phase HPLC, and the product with the elution 
volume of authentic 1B was subjected to high-resolu- 
tion electrospray mass spectrometry.The exact mass was 
determined to be 176.13605, in excellent agreement 
with the value expected for trideuterio-1B 
(C,1H,,2H,0, requires 176.13636). Another peak was 
observed in the mass spectrum at 158.12633, in simi- 
larly close agreement with the mass value expected for 
loss of water from trideuterio-1B (C,1H,,2H,0, 
requires 158.12652). 
These data taken together firmly establish that de novo 
synthesis of compound 1C and trideuterio-1B is occur- 
ring in the cell-free system, the first unequivocal 
demonstration of polyketide chain extension on a 
modular type I PKS in vitro. 
Significance 
The modular type I polyketide synthases of 
Streptomyces and related Gram-positive bacteria 
constitute a unique family of carbon-chain- 
forming multienzymes that are responsible for the 
biosynthesis of a large number of structurally- 
diverse natural products, including antibiotics and 
immunosuppressants. The most intensively- 
studied of these multienzymes, the 6-deoxy- 
erythronolide B synthase of Succharo~oZys~oru 
erythrueu, is one of the simplest, with three differ- 
ent multienzyme subunits housing a total of 
about 30 active sites. Even for this relatively 
simple synthase, however, the complexity of the 
enzymology has frustrated previous attempts to 
demonstrate polyketide synthesis in vitro. 
We have recently introduced a method of specify- 
ing the length of polyketide chain released from a 
modular polyketide synthase by using genetic 
manipulation to relocate the chain-terminating 
cyclase domain (TE) from DEBS3 to the carboxyl- 
terminus of DEBSl. Strains of S. erythvueu harbour- 
ing the fused DEBSl-TE efficiently accumulate 
the anticipated triketide lactone. 
We have now purified DEBSl-TE from such a 
strain and used it to synthesize triketide lactones 
in vitro. We have shown that the specificity for the 
starter unit is more relaxed than in ho, and con- 
firmed that the enzyme specifically uses the (2s)- 
isomer of methylmalonyl-CoA for chain 
extension. The demonstration that in vitro synthe- 
sis of polyketides is possible opens the way for 
detailed mechanistic studies of the modular 
polyketide synthases. Such systems, both in viva 
and in vitro, are of great current interest for syn- 
thesis of novel polyketides of potential utility as 
lead compounds in drug discovery. 
Materials and methods 
Materials 
Coenzyme A esters were purchased from Sigma. (R,S)-[3-14C]- 
methylmalonyl-Cob was purchased from NEN. [i4C]-propi- 
onyl-CoA and [3-2H&propionyl-CoA were synthesized from 
[14C]-propionic acid and [3-2H,J-propionic acid using Sacetyl- 
CoA synthetase, coenzyme A and ATP [7], purified by Mono-Q 
(Pharmacia) anion exchange chromatography followed by desalt- 
ing on Sephadex G-10 . Purity was checked by TLC on cellulose 
in n-butanokacetic acidwater (5:2:3 by vol.) followed by staining 
with sodium nitroprusside. Negative ion mass spectrometry using 
aVG BIO-Q mass spectrometer showed a molecular ion at 825, 
as expected for [3-2H,J-propionyl-CoA. 
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Preparation of [14Cl-triketide lactone IB 
A 250-ml flask containing 100 ml sucrose-succinate defined 
medium was inoculated with S. evythruea TED8 spores [12]. 
After 12 days, the cells were harvested and resuspended in 
100 ml 3-(N-morpholino)-propanesulfonic acid:KOH buffer, 
pH 7.0. Sodium [I-14C]-propionate (4 p,Ci) was added.After 
incubation for a further 24 h the cells were harvested and the 
supernatant extracted with two loo-ml volumes of ethyl 
acetate, dried over MgSO, and concentrated. When analyzed 
by TLC and HPLC, this material appeared identical to 
authentic [14C]-labelled compound 1B [13]. 
Growth of cells, preparation of the extract and 
purification of DEBSI-TE 
Sucrose-succinate defined medium (IO 1) was inoculated with 
a 72 h culture of S. erythraea JCBlOl grown from spores in 400 
ml Ml-102 medium. S. erythraea JCBlOl is a variant of S. ery- 
thvuea TER43 [12] that produces slightly higher levels of tri- 
ketide lactones.After 36 h of growth at 30 “C and 15 1 min-l 
aeration, cells were harvested by filtration. Cell paste (2.5 g) 
was homogenized in 10 ml 50 mM Tris-HCl buffer pH 7.5, 
1 mM EDTA, 20 % v/v glycerol, 2 mM dithiothreitol, 1 mM 
phenanthroline, 1 mM benzamidine, 20 pg ml-l trypsin 
inhibitor, 100 Fg ml-l DNase I and 50 Fg ml-’ RNase A. Cells 
were broken at 1.1 GPa in a French pressure cell and the lysate 
clarified by ultracentrifugation at 100 000 g for 30 min at 4 “C. 
Desalting of the extract, where required, was performed on 
Sephadex G-25 M. Purification of the DEBSl-TE was per- 
formed essentially as described for DEBS multienzymes from 
S. erythraea [8] and for over-expressed DEBS3 in E. coli [18]. 
Full details of the purification and characterization of 
DEBSl-TE will be published separately. 
Assay conditions 
Assays were carried out in the presence of 300 PM propionyl- 
CoA, 600 FM (R,S)-methylmalonyl-CoA, 600 PM NADPH, 
14.6 Funits methylmalonyl-CoA epimerase per ml extract 
[14]. After incubation at 30 “C for 90 min, the reaction was 
stopped by snap-freezing in a dry ice/acetone bath. Reaction 
mixtures were acidified to pH 3.0 with 100 mM H,SO, 
and extracted twice with an equal volume of ethyl acetate. 
Acetyl-CoA, n-butyryl-Cob, iso-butyry-CoA, n-valery- 
CoA, iso-valeryl-CoA, n-hexanoyl-CoA and crotonoyl-Coil 
were used in some assays instead of propionyl-CoA 
For assays on a small scale, loo-k1 aliquots of cell extract were 
added to the above components in a final volume of 120 ~1. 
With purified enzyme, 125 p,g of protein was used in the 
same final volume of 50 mM Tris-HCl buffer pH 7.5,l mM 
EDTA, 20 % v/v glycerol, 2 mM dithiothreitol.These small- 
scale assays included 27 nCi [3-14C]-(R,S)-methylmalonyl- 
CoA. Products were separated by TLC on silica plates, eluted 
twice with diethyl ether, and two-dimensional scanning was 
performed with a Molecular Dynamics PhosphorimagerTM 
425. Normal-phase HPLC was carried out on a Hewlett 
Packard HP1090 instrument, using a Spherisorb SW5 
column (PhaseSep, 5 pm, 25 cm x 4.6 mm) developed iso- 
cratically with diethyl ether/cyclohexane (1:1 v/v) at a flow 
rate of 1 ml min-l. Reversed-phase HPLC was carried out on 
a Spherisorb S5CN column (PhaseSep, 5 pm, 25 cm x 
4.6 mm) developed with a linear gradient from 
methanol/water (I:9 v/v) to methanol/water (1:1 v/v) at a 
flow rate of 1 ml min-I. Where appropriate, 0.5 ml fractions 
were collected and the radioactivity counted using Optiphase 
‘Hisafe’ scintillant in a Canberra Packard 2000CA Tricarb 
Liquid Scintillation Counter. 
Large-scale assays with 2H3-propionyl-CoA or n-butyryl-Coil, 
for which no radiolabel was required, were carried out as 
described above but in a final volume of 22 ml. Products were 
separated by HPLC as before and analyzed by mass spectrome- 
try on aVG-BIOQ mass spectrometer. 
The stereospecificity of polyketide chain extension 
To remove the (2S)-isomer of methylmalonyl-CoA, 2.4 mM 
(R,S)-methylmalonyl-CoA (containing 27 nCi (R,S)-[3-14C]- 
methylmalonyl-CoA) was incubated for 20 min at 30°C in the 
presence of 100 units (U) malate dehydrogenase, 11 mM 
NADH, 11 mM sodium pyruvate and either 200 mu, 20 mu, 
2 mu, 0.2 mU or 0 mU of transcarboxylase, respectively, in a 
final volume of 100 ~1 50 mM Tris-HCl buffer pH 7.5. After 
20 min, propionyl-CoA (final concentration 300 mM), 
NADPH (final concentration 600 PM) and 125 Fg 
DEBSl-TE (90 % pure) were added and the 200-~1 mixture 
was incubated for 60 min. To a parallel incubation with 
200 mU transcarboxylase, 200 mU methylmalonyl-CoA 
epimerase was added simultaneously with the DEBSI-TE. 
To remove the (2R)-isomer, 2.4 m&l (R,S)-methylmalonyl- 
CoA (containing 27 nCi (R,5’)-[3-14C]-methylmalonyl-CoA) 
was incubated for 20 min at 30°C in the presence of IO mM 
MgCl,, 0.1 mM EDTA, 4 mM arsenate, 0.23 U succinyl-CoA 
synthetase (the kind gift of Professor J. Nishimura, University 
of Texas), 5 PM coenzyme B,, and 200 mu, 20 mu, 2 mu, 
0.2 mU and 0 mU respectively of methylmalonyl-CoA mutase 
in a final volume of 100 ~1 100 mM Tris-HCl, pH 8.0. After 
20 min, assays were carried out as above. To another incubation 
with 200 mU mutase, 200 mU methylmalonyl-CoA epimerase 
was added and after a further 20 min incubation at 30°C the 
assay was started with the addition of propionyl-CoA, 
NADPH and DEBSI-TE 
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